Login
surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants
surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants
surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants
 Next

surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants

Marsoni M251S
Sale price$27.81
Pay 4 payments of $6.95 a month.Shop Pay
Get it in 3 business days with 1 day shipping. Friday, May 29
Foods to Eat While Taking Tirzepatide: A Nigerian Meal Guide HueBeautyGlam Tirzepatide Side Effects and How to Overcome Them Heally In the SURMOUNT 5 phase 3b trial involving adults with obesity without type 2 diabetes, tirzepatide was superior to semaglutide in reducing body weight and waist circumference. Full trial results and Research Summary: COMPOUNDED SEMAGLUTIDE Fitish
Easy Shipping

Quick Dispatch:

Your surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants orders ship within 1-2 business days.

Delivery Options:

  • Standard: 3-7 business days
  • Fast: 2-3 business days
  • Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants ships.

Need Help?
Questions about surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants in your area.

Get Shipping Estimates

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
4.8 ★★★★★
Based on 1836 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
R
Verified Purchase
Renae Halvorson
Fort Morgan, US
★★★★★ 4
Value for your money
Style: EcoFetch
It's definitely different from the one I lost. It's taking me some time how to throw the ball correctly. It's a hit and miss but we are getting there. When I do get a good throw, it really wings it out there.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 17, 2026
W
Verified Purchase
Will Brannies
Carnegie, US
★★★★★ 5
Well worth it
Style: EcoFetch
Works great
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 20, 2026
J
Verified Purchase
Jennifer Stenson
Whiting, US
★★★★★ 5
Perfect for active dogs
This is a must-have if your dog loves to fetch. It throws the ball far with very little effort and keeps your hands clean—no more slobbery chuckit balls. Lightweight, durable, and makes playtime much more fun (and less tiring for me!).
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 9, 2026
J
Verified Purchase
John J
Whiting, US
★★★★★ 5
Way better than the M size for us
Like most people that have dogs I first went with the M size or Tennis ball size (about 2.5") chuckit for my 65-70 lbs Lab. After having that for a while and my dogs' evolution from liking to chase the ball to wanting to catch it, I started seeing how the M size could cause some life threating problems for my pup. I was on the fence for several weeks when I came across this option that included a 3" ultra ball as well as a 3" fuzzy tennis ball like ball. These balls can fly so much farther with less effort and my furry friend seeming to like them more than the 2.5 inch. It also seems to fit their mouth better allowing them to enjoy 'the game' (you lost by the way) much more. If you have a larger dog or your dog has a big mouth, please trust me when I say skip the 2.5" M size balls. You and your dog will haves much more fun with this 3" size
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 10, 2024
D
Verified Purchase
Donna Sue
Massapequa, US
★★★★★ 5
Chuck it ball launcher
This is great! I have a blue healer that loves it. She will play fetch with the ball all day long. The launcher is easier on my shoulder. I can throw the ball twice as far and when she brings the ball back I can grab it with the launcher without touching a spit covered ball. Awesome buy!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 2, 2025

recommand products

Do Ozempic and Other Weight-Loss Drugs Cause Vision Loss?
Do Ozempic and Other Weight-Loss Drugs Cause Vision Loss?
28.73
 Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide
29.01
 Lawsuit Alleges Novo Nordisk Downplayed Ozempic Gastroparesis Risks
Lawsuit Alleges Novo Nordisk Downplayed Ozempic Gastroparesis Risks
26.43
 West Virginia Ozempic Lawsuit Lawyer
West Virginia Ozempic Lawsuit Lawyer
23.43
 Wegovy® Lawsuit
Wegovy® Lawsuit
29.17